4Sinclair JC, Haynes RB. Selecting participants that raise a clinical trial's population attributable fraction can increase the treatment effect within the trial and reduce the required sample size [ J ]. J Clin Epidemiol, 2011,64 ( 8 ) : 893-902. 被引量：1
5Friede T, Kieser M. Sample size reassessment in non- inferiority trials. Internal pilot study designs with ANCOVA [J]. Methods Inf Med, 2011,50(3) :237-243. 被引量：1
6Boyd KA, Briggs AH, Fenwick E, et al. Power and sample size for cost-effectiveness analysis : fFN neonatal screening[J ]. Contemp Clin Trials, 2011,32(6) : 893-901. 被引量：1
7Navaneethan SD, Palmer SC, Smith A, et at. How to design a randomized controlled trial [J]. Nephrology (Carlton), 2010,15(8) :732-739. 被引量：1
8Jun M, Zoungas S, Perkovic V, et al. How to read a report of a randomized controlled trial [J]. Nephrology (Carlton), 2010,15(2) : 153-157. 被引量：1
9Skornpski KA, Hammond GM, Irish AM, et al. Prospective randomized clinical trial assessing the efficacy of Denamarin for prevention of CCNU-induced hepatopathy in tumor-bearing dogs [ J ]. J Vet Intern Med, 2011,25 (4) : 838- 845. 被引量：1
